Essentials of Medical Pharmacology (Record no. 19792)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 05152nam a22001817a 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OSt |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240514145432.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 231012b xxu||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9789352704996 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Edition number | 8th |
Classification number | 615.1 TRI |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Author name | Tripathi,K D |
245 ## - TITLE STATEMENT | |
Title | Essentials of Medical Pharmacology |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc. | New Delhi |
Name of publisher, distributor, etc. | Jaypee Brothers Medical Pub. |
Date of publication, distribution, etc. | 2023 |
300 ## - PHYSICAL DESCRIPTION | |
Page | 1122p. |
500 ## - GENERAL NOTE | |
General note | Contents<br/>SECTION 1<br/>General Pharmacological Principles<br/>1. Introduction, Routes of Drug Administration<br/>2. Pharmacokinetics: Membrane Transport, Absorption and Distribution of Drugs<br/>3. Pharmacokinetics: Metabolism and Excretion of Drugs, Kinetics of Elimination<br/>4. Pharmacodynamics: Mechanism of Drug Action; Receptor Pharmacology<br/>6. Adverse Drug Effects<br/>5. Aspects of Pharmacotherapy, Clinical Pharmacology and Drug Development<br/>SECTION 2<br/>Drugs Acting on Autonomic Nervous System<br/>Autonomic Nervous System: General Considerations<br/>7. Cholinergic Transmission and Cholinergic Drugs<br/>8. Anticholinergic Drugs and Drugs Acting on Autonomic Ganglia<br/>9. Adrenergic Transmission and Adrenergic Drugs<br/>10. Antiadrenergic Drugs (Adrenergic Receptor Antagonists) and Drugs for Glaucoma<br/>SECTION 3<br/>Autacoids and Related Drugs<br/>11. Histamine and Antihistaminics<br/>12. 5-Hydroxytryptamine, its Antagonists and Drug Therapy of Migraine<br/>13. Prostaglandins, Leukotrienes (Eicosanoids) and Platelet Activating Factor<br/>14. Nonsteroidal Antiinflammatory Drugs and Antipyretic-Analgesics<br/>15. Antirheumatoid and Antigout Drugs<br/>Respiratory System Drugs<br/>16. Drugs for Cough and Bronchial Asthma<br/>ESSENTIALS OF MEDICAL PHARMACOLOGY<br/>SECTION 5<br/>Introduction<br/>Hormones and Related Drugs<br/>17. Anterior Pituitary Hormones<br/>18. Thyroid Hormones and Thyroid Inhibitors<br/>19. Insulin, Oral Antidiabetic Drugs and Glucagon<br/>20. Corticosteroids<br/>21. Androgens and Related Drugs, Drugs for Erectile Dysfunction<br/>22. Estrogens, Progestins and Contraceptives<br/>23. Oxytocin and Other Drugs Acting on Uterus<br/>24. Hormones and Drugs Affecting Calcium Balance<br/>SECTION 6<br/>Drugs Acting on Peripheral (Somatic) Nervous System<br/>25. Skeletal Muscle Relaxants<br/>26. Local Anaesthetics<br/>SECTION 7<br/>Drugs Acting on Central Nervous System<br/>27. General Anaesthetics<br/>28. Ethyl and Methyl Alcohols<br/>29. Sedative-Hypnotics<br/>30. Antiepileptic Drugs<br/>31. Antiparkinsonian Drugs<br/>32. Drugs Used in Mental Illness: Antipsychotic and Antimanic Drugs 33. Drugs Used in Mental Illness: Antidepressant and Antianxiety Drugs<br/>34. Opioid Analgesics and Antagonists<br/>35. CNS Stimulants and Cognition Enhancers<br/>SECTION 8<br/>Cardiovascular Drugs<br/>Cardiac Electrophysiological Considerations<br/>36. Drugs Affecting Renin-Angiotensin System<br/>37. Nitric Oxide and Vasoactive Peptide Signal Molecules<br/>38. Cardiac Glycosides and Drugs for Heart Failure<br/>39. Antiarrhythmic Drugs<br/>40. Antianginal and Other Anti-ischaemic Drugs<br/>41. Antihypertensive Drugs<br/>CONTENTS<br/>SECTION 9<br/>Drugs Acting on Kidney<br/>Relevant Physiology of Urine Formation<br/>42. Diuretics<br/>SECTION 10<br/>43. Antidiuretics<br/>62<br/>62<br/>63<br/>Drugs Affecting Blood and Blood Formation<br/>44. Haematinics and Erythropoietin<br/>45. Drugs Affecting Coagulation, Bleeding and Thrombosis<br/>46. Hypolipidaemic Drugs<br/>SECTION 11<br/>Gastrointestinal Drugs<br/>47. Drugs for Peptic Ulcer and Gastroesophageal Reflux Disease<br/>48. Antiemetic, Prokinetic and Digestant Drugs<br/>49. Drugs for Constipation and Diarrhoea<br/>SECTION 12<br/>Antimicrobial Drugs<br/>50. Antimicrobial Drugs: General Considerations<br/>51. Sulfonamides, Cotrimoxazole and Quinolones<br/>52. Beta-Lactam Antibiotics<br/>53. Tetracyclines and Chloramphenicol (Broad-Spectrum Antibiotics)<br/>54. Aminoglycoside Antibiotics<br/>55. Macrolide, Lincosamide, Glycopeptide and Other Antibacterial Antibiotics;<br/>Urinary Antiseptics<br/>56. Antitubercular Drugs<br/>57. Antileprotic Drugs<br/>58. Antifungal Drugs<br/>59. Antiviral Drugs (Non-retroviral)<br/>60. Antiviral Drugs (Anti-retrovirus)<br/>61. Antimalarial Drugs<br/>62. Antiamoebic and Other Antiprotozoal Drugs<br/>63. Anthelmintic Drugs<br/>ESSENTIALS OF MEDICAL PHARMACOLOGY<br/>SECTION 13<br/>Chemotherapy of Neoplastic Diseases<br/>64 Anticancer Drugs<br/>SECTION 14<br/>Miscellaneous Drugs<br/>65. Immunosuppressant Drugs<br/>66. Drugs Acting on Skin and Mucous Membranes<br/>67. Antiseptics, Disinfectants and Ectoparasiticides<br/>68. Chelating Agents<br/>69. Vitamins<br/>70. Vaccines, Antisera and Immuneglobulins<br/>71. Drug Interactions<br/>Appendices<br/>Appendix 1: Solution to Problem Directed Study<br/>Appendix 2: Prescribing in Pregnancy<br/>Appendix 3: Drugs in Breastfeeding<br/>Appendix 4: Drugs and Fixed Dose Combinations Banned in India<br/>Selected References for Further Reading<br/>Additional Competency Topics<br/>Prescription Writing<br/>P-Drugs<br/>Drugs used for Criminal Offences<br/>Drug Deaddiction<br/>Plasma Expanders<br/>Colony Stimulating Factors<br/>Antibiotic Stewardship Program<br/>Pesticides<br/>Insect Repellents<br/>Pollutants<br/>Food Adulterants<br/>Management of Common Poisonings, Bites and Stings<br/>National Health Programs<br/>Over-the-Counter Drugs<br/>Herbal Medicines<br/>Pharmacoeconomics<br/>Dietary Supplements and Nutraceuticals<br/>Drug Regulations, Acts and other Legal Aspects |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Subject heading | Nervous Syatem,Cardiovascular Drugs |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Dewey Decimal Classification |
Koha item type | BOOKS |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection code | bill no. | bill date | Home library | Current library | Date acquired | Source of acquisition | Coded location qualifier | Cost, normal purchase price | Total Checkouts | Full call number | Accession No | Date last seen | Price effective from | Koha item type | Public note |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dewey Decimal Classification | Not For Loan | MAMCRC | N5/INV-I/23-00295 | 05/10/2023 | MAMCRC LIBRARY | MAMCRC LIBRARY | 12/10/2023 | Jaypee Brothers Medical Pub. | REF | 1750.00 | 615.1 TRI | A5079 | 30/01/2025 | 12/10/2023 | BOOKS | Reference Books |